Barry D Quart - Net Worth and Insider Trading
Barry D Quart Net Worth
The estimated net worth of Barry D Quart is at least $253,667 dollars as of 2024-04-24. Barry D Quart is the CEO of Heron Therapeutics Inc and owns about 94,652 shares of Heron Therapeutics Inc (HRTX) stock worth over $253,667. Barry D Quart is also the Director of Kiniksa Pharmaceuticals Ltd and owns about 0 shares of Kiniksa Pharmaceuticals Ltd (KNSA) stock worth over $0. Details can be seen in Barry D Quart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Barry D Quart has not made any transactions after 2022-11-29 and currently still holds the listed stock(s).
Transaction Summary of Barry D Quart
Barry D Quart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barry D Quart owns 2 companies in total, including Heron Therapeutics Inc () , and Kiniksa Pharmaceuticals Ltd () .
Click here to see the complete history of Barry D Quart’s form 4 insider trades.
Insider Ownership Summary of Barry D Quart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Heron Therapeutics Inc | 2019-10-03 | director & Chief Executive Officer | |
| Kiniksa Pharmaceuticals Ltd | 2022-11-29 | director |
Barry D Quart Latest Holdings Summary
Barry D Quart currently owns a total of 2 stocks. Among these stocks, Barry D Quart owns 94,652 shares of Heron Therapeutics Inc (HRTX) as of October 3, 2019, with a value of $253,667 and a weighting of 100%. Barry D Quart also owns 0 shares of Kiniksa Pharmaceuticals Ltd (KNSA) as of November 29, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Barry D Quart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2019-10-03 | 94,652 | 2.68 | 253,667 |
| KNSA | Kiniksa Pharmaceuticals Ltd | 2022-11-29 | 0 | 17.99 | 0 |
Holding Weightings of Barry D Quart
Barry D Quart Form 4 Trading Tracker
According to the SEC Form 4 filings, Barry D Quart has made a total of 1 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Heron Therapeutics Inc is the acquisition of 4,571 shares on October 3, 2019, which cost Barry D Quart around $79,993.
According to the SEC Form 4 filings, Barry D Quart has made a total of 1 transactions in Kiniksa Pharmaceuticals Ltd (KNSA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kiniksa Pharmaceuticals Ltd is the sale of 21,959 shares on November 29, 2022, which brought Barry D Quart around $354,638.
Insider Trading History of Barry D Quart
- 1
Barry D Quart Trading Performance
GuruFocus tracks the stock performance after each of Barry D Quart's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barry D Quart is 18.22%. GuruFocus also compares Barry D Quart's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barry D Quart within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Barry D Quart's insider trading performs compared to the benchmark.
Performance of Barry D Quart
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.46 | 18.22 | -39.65 | -24.57 | -25.29 | -39.24 |
| Relative Return to S&P 500(%) | 6.09 | 7.08 | -25.15 | -39.61 | -47.67 | -47.35 |
Barry D Quart Ownership Network
Ownership Network List of Barry D Quart
Ownership Network Relation of Barry D Quart
Barry D Quart Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
Barry D Quart is the director & Chief Executive Officer of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Barry D Quart made no insider transaction in Heron Therapeutics Inc (). Other recent insider transactions involving Heron Therapeutics Inc () include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc () were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
Barry D Quart Mailing Address
Above is the net worth, insider trading, and ownership report for Barry D Quart. You might contact Barry D Quart via mailing address: C/o Intrabiotics Pharmaceuticals Inc, 1009 Oak Hill Road, Suite 201, Lafayette Ca 94549.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
